These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24984883)

  • 21. Postoperative intravenous administration of lysine acetylsalicylate: effect on pain relief and platelet function.
    Hanaue H; Ogoshi K; Makuuchi H; Mitomi T; Kurosawa T; Nemoto A; Kitano Y; Miyakawa S; Yamoto H; Asagoe T
    Clin Ther; 1987; 9(2):159-66. PubMed ID: 3105886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes.
    Abaci A; Yilmaz Y; Caliskan M; Bayram F; Cetin M; Unal A; Cetin S
    Thromb Res; 2005; 116(6):465-70. PubMed ID: 16181981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial.
    Paikin JS; Hirsh J; Ginsberg JS; Weitz JI; Chan NC; Whitlock RP; Pare G; Johnston M; Eikelboom JW
    J Thromb Haemost; 2015 Mar; 13(3):448-56. PubMed ID: 25546465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
    Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating resistance to acetyl salicylic acid using platelet function test in patients with ischemic stroke at Cipto Mangunkusumo Hospital.
    Kurniawan M; Harris S; Hermawan D; Prihartono J
    Acta Med Indones; 2015 Apr; 47(2):88-94. PubMed ID: 26260550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease.
    Cao J; Liu L; Fan L; Chen T; Hu G; Hu Y; Zhu B; Li J; Wang H; Li X
    Aging Male; 2012 Sep; 15(3):140-7. PubMed ID: 22452804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period.
    Baha RM; Özdöl Ç; Güleç S; Erol Ç
    Turk Kardiyol Dern Ars; 2015 Jul; 43(5):443-9. PubMed ID: 26148076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus.
    Mehta SS; Silver RJ; Aaronson A; Abrahamson M; Goldfine AB
    Am J Cardiol; 2006 Feb; 97(4):567-70. PubMed ID: 16461058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of aspirin resistance in type 2 diabetes.
    Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
    J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment methods for aspirin-mediated platelet antiaggregation in type 2 diabetic patients: degree of correlation between 2 point-of-care methods.
    Cubero Gómez JM; Navarro Puerto MA; Acosta Martínez J; De Mier Barragán MI; Pérez Santigosa PL; Sánchez Burguillos F; Molano Casimiro F; Pastor Torres L
    J Cardiovasc Pharmacol; 2014 Jul; 64(1):16-20. PubMed ID: 24553145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
    Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
    Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin resistance in patients with chronic renal failure.
    Tanrikulu AM; Ozben B; Koc M; Papila-Topal N; Ozben T; Caymaz O
    J Nephrol; 2011; 24(5):636-46. PubMed ID: 21279952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    Angiolillo DJ; Capranzano P; Goto S; Aslam M; Desai B; Charlton RK; Suzuki Y; Box LC; Shoemaker SB; Zenni MM; Guzman LA; Bass TA
    Eur Heart J; 2008 Sep; 29(18):2202-11. PubMed ID: 18567918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients.
    Mateos-Cáceres PJ; Macaya C; Azcona L; Modrego J; Mahillo E; Bernardo E; Fernandez-Ortiz A; López-Farré AJ
    Thromb Haemost; 2010 Jan; 103(1):160-70. PubMed ID: 20062920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.